Toxikon is a preclinical contract research organization (CRO). We ...

Corporate Overview
Toxikon At A Glance
Services
Capabilities
»»
In Vivo Services
»»
In Vitro Services
»»
Analytical/Bioanalytical
»»
Support and Specialty
Programs
Locations:
Corporate Headquarters
Toxikon Corporation
15 Wiggins Avenue
Bedford, MA 01730
800.458.4141
info@toxikon.com
www.toxikon.com
Toxikon Europe N.V.
Romeinsestraat 12
B-3001 Leuven
Belgium
+32.16.400484
info@toxikon.be
www.toxikon.be
Toxikon is a preclinical contract research organization
(CRO). We contract and partner with biotech,
pharmaceutical and medical device industries to deliver
exceptional product development services from concept to
final product.
No matter what your development needs, you can rely on Toxikon to be a flexible partner
with technical research and development expertise to meet your project goals
for timely market launch.
We not only provide you with excellent service, we also work closely and collaborate
with you so that we understand your needs to develop a comprehensive testing program
well aligned to meet your development objectives. As a leading preclinical CRO, Toxikon
has the experience and is a proven life science leader with a staff of scientific distinction
who can provide in vivo, in vitro, analytical, and a host of other services central to the
development of products designed to improve the quality of life.
With Toxikon you gain a strategic and responsive scientific partner, who not only brings
reliability, trust, and flexibility to your projects, but also the assurance to align with your
corporate goals, achieve product safety and regulatory compliance, and maintain the
highest levels of environmental and manufacturing quality control.
Whether you are a pharmaceutical, medical device or biotech company, collaborating
with Toxikon provides you access to a team of experts experienced in a comprehensive
range of compound structures, therapeutic targets as well as medical devices and
combination products.
A Resourceful CRO
»»
Toxikon’s Massachusetts campus, located in the heart of Bay State’s life science
research hub, has more than 125,000 square feet of facility space dedicated to the
development of compounds, biologics, and medical devices;
»»
Toxikon Europe operates a 14,000-square-foot facility in Leuven,
Belgium, to meet the needs of European pharmaceutical, biotech
and medical device industries;
»»
An experienced international team;
»»
A highly educated and trained workforce;
»»
Broad technical expertise with recognized scientific excellence;
»»
World-class facilities in the United States and Europe;
»»
Client/Sponsor-centric;
»»
Collaborative and research-oriented culture.
www.toxikon.com

Corporate Overview
Services at a Glance
Toxikon is an ISO/IEC 17025-accredited Contract Research Organization (CRO) registered with the FDA for drug,
biologics, and medical device testing. With approximately 200 employees, Toxikon is committed to staying at the
forefront of life science technology development. Toxikon’s safety services include toxicology (acute, subchronic,
and chronic toxicity, reproductive toxicity, genetic toxicology, carcinogenicity), pharmacokinetics, toxicokinetics,
bioavailability, ADME, chemical characterization, impurities analysis and synthesis, bioanalysis, and microbiology.
Toxikon’s extensive certifications and licenses allow it to meet international regulatory requirements for data acceptability
and harmonization.
To meet all applicable international GxP requirements, Toxikon’s facilities are fully registered with FDA and USDA, and
accredited with the Association for the Assessment and Accreditation of Laboratory and Animal Care International
(AAALAC), and the International Organization for Standardization (ISO). Toxikon also has assurance with the National
Institutes of Health so federally funded work can be performed at our facilities in compliance with NIH’s Public Health
Service Policy on Human Care and Use of Laboratory Animals (PHS Policy).
Services for Medical
Device Developers
»»
In Vivo
- Sensitization/
Reactivity
- Acute, Subchronic and
Chronic Toxicology
- Implantation
»»
In Vitro
- Cytotoxicity
- Genetic Toxicology
- Hemocompatibility
- Microbiology
»»
Analytical
- Material
Characterization
- Extractables and
Leachables
- Compendial Testing
Services for Drug
Developers
»»
In Vivo
- Whole Animal Assays-
PK/TK/ADME/DMPK
- Toxicology/IND
Enabling Studies
- Small/Large
Animal Models
- Imaging
»»
In Vitro
- Binding Assays
- Cell Culture Based
Assays
- Molecular
Biology/Virology
- Genetic Toxicology
- Microbiology
- Immunogenicity
»»
Analytical/Bioanalytical
- Method Development
- Method Validation
- Comprehensive GLP/
GMP Assays
Services for Biotech
Product Developers
»»
In Vivo
- In Vivo Pharmacology
- Toxicology/
Immunotoxicology
- PK/TK
»»
In Vitro
- Potency Assays
- RIA/ELISA/PCR
- Viral Clearance
»»
Analytical/Bioanalytical
- Method Development
and Validation
- Protein
Characterization
- Stability/Aging and
Release Testing
- Bioanalytical Sample
Analysis
Custom Services
»»
Ocular Drug Program
»»
Proof of Concept
»»
Surgical Programs
»»
R&D
»»
Discovery
»»
Synthesis and
Formulation
»»
Reproductive Toxicology
»»
Immunohistochemistry
and Pathology
»»
Imaging Capabilities
Please visit www.toxikon.com to learn more about our preclinical development capabilities.
15 Wiggins Avenue Bedford, MA 01730 800.458.4141 info@toxikon.com www.toxikon.com